The FDA's Ban of Therapeutic Peptides: A Threat to Health Freedom Slim 'n Sleek When will the FDA reclassify BPC 157 to Category 1 Octagon AI The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA to weigh easing limits on unproven peptides favored by RFK Jr. BPC 157 Cost: What You Need to Know